King Wealth Abbott Laboratories Transaction History

King Wealth

$600 Million
Q2 2024

A detailed history of King Wealth transactions in Abbott Laboratories stock. As of the latest transaction made, King Wealth holds 10,723 shares of ABT stock, worth $1.22 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

10,723

Previous 10,676 0.44%

Holding current value

$1.22 Million

Previous $1.21 Million 8.16%

% of portfolio

0.19%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $4,734 - $5,284	47 Added 0.44%	10,723 $1.11 Million
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $7,228 - $7,983	66 Added 0.62%	10,676 $1.21 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $6,764 - $8,280	75 Added 0.71%	10,610 $1.17 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $32,671 - $39,200	-342 Reduced 3.14%	10,535 $1.02 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $43,033 - $47,947	427 Added 4.09%	10,877 $1.19 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $2,421 - $2,850	25 Added 0.24%	10,450 $1.06 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $29,753 - $34,905	313 Added 3.1%	10,425 $1.15 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $19,545 - $22,630	202 Added 2.04%	10,112 $978,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $2,143 - $2,590	21 Added 0.21%	9,910 $1.08 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $28,276 - $34,481	-248 Reduced 2.45%	9,889 $1.17 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $33,619 - $41,164	-291 Reduced 2.79%	10,137 $1.43 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $2,216 - $2,452	-19 Reduced 0.18%	10,428 $1.23 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $211 - $249	2 Added 0.02%	10,447 $1.21 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $217 - $256	2 Added 0.02%	10,445 $1.25 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $36,435 - $39,703	-347 Reduced 3.22%	10,443 $1.14 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $183 - $222	2 Added 0.02%	10,790 $1.17 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $15,390 - $19,698	201 Added 1.9%	10,788 $986,000
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $4,962 - $7,256	79 Added 0.75%	10,587 $835,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $6,437 - $7,166	82 Added 0.79%	10,508 $913,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $9,902 - $10,737	121 Added 1.17%	10,426 $873,000
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $50,797 - $59,245	697 Added 7.25%	10,305 $867,000
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $3,642 - $4,403	-55 Reduced 0.57%	9,608 $768,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $15,996 - $18,121	244 Added 2.59%	9,663 $699,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $121 - $146	2 Added 0.02%	9,419 $691,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $115 - $127	2 Added 0.02%	9,417 $574,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $3,263 - $3,689	58 Added 0.62%	9,415 $564,000
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $107 - $114	2 Added 0.02%	9,357 $534,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $96 - $107	2 Added 0.02%	9,355 $499,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,353	9,353 $455,000

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.

Account